Guobin Wang
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Biomaterials top 1%
- Silk-based biomaterials and applications
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 13
- Epigenetics and DNA Methylation 8
- Oncology 52
- Cancer Immunotherapy and Biomarkers 12
- Colorectal Cancer Treatments and Studies 8
- Co-authors
- Lin Wang (53 shared papers)Zheng Wang (52 shared papers)Kaixiong Tao (86 shared papers)Weiping Zou (11 shared papers)Ke Wu (19 shared papers)Ende Zhao (14 shared papers)Ilona Kryczek (9 shared papers)Luming Xu (18 shared papers)
- Journals
- Oncotarget (9 papers)Medicine (7 papers)Biomaterials (6 papers)ACS Applied Materials & Interfaces (6 papers)Frontiers in Oncology (5 papers)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Guobin Wang
213 papers receiving 6.7k citations
Peers
Comparison fields: 5 of 154
- Immunology 1.8k
- Biomaterials 890
- Oncology 1.5k
- Cancer Research 836
- Molecular Biology 2.1k
Countries citing papers authored by Guobin Wang
This map shows the geographic impact of Guobin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Wang more than expected).
Fields of papers citing papers by Guobin Wang
This network shows the impact of papers produced by Guobin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Wang. The network helps show where Guobin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guobin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 410 | |
| 2 | 2018 | 343 | |
| 3 | 2011 | 270 | |
| 4 | 2011 | 218 | |
| 5 | 2015 | 214 | |
| 6 | 2018 | 210 | |
| 7 | 2019 | 177 | |
| 8 | 2022 | 168 | |
| 9 | 2009 | 152 | |
| 10 | 2011 | 142 | |
| 11 | 2016 | 128 | |
| 12 | 2012 | 123 | |
| 13 | 2019 | 106 | |
| 14 | 2010 | 98 | |
| 15 | 2022 | 92 | |
| 16 | 2016 | 89 | |
| 17 | 2017 | 88 | |
| 18 | 2010 | 82 | |
| 19 | 2021 | 81 | |
| 20 | 2017 | 78 |
About Guobin Wang
Guobin Wang is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Immunology, having authored 220 papers that have together received 6.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), RNA Interference and Gene Delivery (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Immune Cell Function and Interaction (12 papers), Gastric Cancer Management and Outcomes (11 papers), Nanoparticle-Based Drug Delivery (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Immunology (1.8k citations), Biomaterials (890 citations), Oncology (1.5k citations), Cancer Research (836 citations) and Molecular Biology (2.1k citations). Guobin Wang has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Lin Wang, Zheng Wang, Kaixiong Tao, Weiping Zou, Ke Wu, Ende Zhao, Ilona Kryczek, Luming Xu, Xiaoming Shuai and Kaixiong Tao. Their work appears in journals such as Oncotarget, Medicine, Biomaterials, ACS Applied Materials & Interfaces and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.